SCHEMBL7413839

SCHEMBL7413839

NC(c1ccc(F)cc1)C1CCN(CCCOc2ccccc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.54
SIGMAR1 Q99720 3/20 0.54
DRD2 P14416 3/20 0.54
HTR1A P08908 3/20 0.54
TMEM97 Q5BJF2 2/20 0.54
DRD3 P35462 2/20 0.54
HRH1 P35367 1/20 0.54
SLC6A3 Q01959 3/20 0.51
DRD1 P21728 1/20 0.50
DRD5 P21918 1/20 0.50
HTR7 P34969 1/20 0.48
SLC6A2 P23975 2/20 0.48
SLC6A4 P31645 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7408581 0.98 HTR2A (0.52) HTR2ASIGMAR1DRD2HTR1ATMEM97
Hydrochloric Acid SCHEMBL7408580 0.98 HTR2A (0.52) HTR2ASIGMAR1DRD2HTR1ATMEM97
SCHEMBL10559724 0.88 HTR2A (0.56) HTR2ASIGMAR1DRD2HTR1ATMEM97
SCHEMBL10560937 0.87 HTR2A (0.55) HTR2ASIGMAR1DRD2HTR1ATMEM97
SCHEMBL10556014 0.84 HTR2A (0.55) HTR2ASIGMAR1DRD2HTR1ATMEM97
Oxalic Acid SCHEMBL10461397 0.83 KDM4E (0.58) HTR2ASIGMAR1DRD2HTR1ATMEM97
SCHEMBL7410875 0.82 DRD2 (0.50) HTR2ASIGMAR1DRD2HTR1ATMEM97
SCHEMBL10560791 0.81 DRD2 (0.57) HTR2ASIGMAR1DRD2HTR1ATMEM97
SCHEMBL466855 0.81 HRH3 (0.71) HTR2ADRD2HTR1ADRD3DRD1
SCHEMBL10460536 0.81 HTR2A (0.58) HTR2ASIGMAR1DRD2HTR1ATMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5198449-A N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents A. H. ROBINS COMPANY INCORPORATED (US) 1993-03-30 US disclosed